Related Experiment Videos
Management of congestive heart failure in the elderly
1Department of Pharmacy Practice, College of Pharmacy, University of Florida, Gainesville 32610.
Insights
Optimal congestive heart failure (CHF) treatment remains debated, especially for elderly patients. Current evidence suggests enalapril or hydralazine/isosorbide dinitrate improve survival, questioning traditional digitalis glycoside use.
Area of Science:
- Cardiology
- Pharmacology
- Geriatrics
Background:
- The optimal treatment strategy for congestive heart failure (CHF) is not universally agreed upon, particularly in elderly populations.
- Existing research challenges the routine use of digitalis glycosides as a first-line therapy for chronic CHF.
- Diuretics, specifically thiazide diuretics, have been proposed as initial treatment options by some clinicians.
Purpose of the Study:
- To review current evidence on therapeutic agents for congestive heart failure (CHF).
- To evaluate the efficacy of different drug classes in managing chronic CHF, focusing on mortality reduction.
- To identify areas requiring further research in CHF pharmacotherapy.
Main Methods:
- Review of existing clinical studies and pharmacological data.
- Analysis of evidence regarding the impact of digitalis glycosides, diuretics, and vasodilators on CHF outcomes.
- Synthesis of findings to inform treatment guidelines.
Main Results:
- Drug therapy with enalapril has demonstrated a reduction in mortality associated with chronic CHF.
- Combination therapy with hydralazine and isosorbide dinitrate has also shown efficacy in reducing CHF-related mortality.
- The definitive roles of digitalis glycosides and diuretics in current CHF management require further investigation.
Conclusions:
- Current evidence supports the use of enalapril or hydralazine/isosorbide dinitrate for reducing mortality in chronic CHF.
- The established role of digitalis glycosides in CHF treatment warrants re-evaluation.
- Further research is necessary to elucidate the precise therapeutic positioning of diuretics, digitalis glycosides, and vasodilators in comprehensive CHF management.
Abstract:
A universally accepted description of appropriate therapy for treatment of congestive heart failure (CHF) has yet to be agreed upon, especially in the elderly. Numerous studies have provided data that question use of a digitalis glycoside as the agent of choice in treatment of chronic CHF. Several clinicians have suggested that diuretics, particularly thiazide diuretics, be used as initial agents in the treatment of this condition. Evidence now demonstrates that drug therapy with enalapril or the combination of hydralazine and isosorbide dinitrate reduces the mortality related to chronic CHF. Additional studies are required to clarify respective roles of diuretics, digitalis glycosides, and vasodilators in the management of chronic CHF.